APO RESEARCH · REPORT
Glycyrrhetinic Acid (CAS 471-53-4)
Glycyrrhetinic Acid (CAS 471-53-4) (also known as Enoxolone or glycyrrhetic acid) is a pentacyclic triterpenoid derivative of the beta-amyrin type obtained from the hydrolysis of glycyrrhizic acid, which was obtained from the herb liquorice. It is used in flavoring and it masks the bitter taste of drugs like aloe and quinine. It is effective in the treatment of peptic ulcer and also has expectorant (antitussive) properties. It has some additional pharmacological properties including antiviral, antifungal, antiprotozoal, and antibacterial activities.
Product & engineering
Understand the product.
Glycyrrhetinic Acid (CAS 471-53-4) (also known as Enoxolone or glycyrrhetic acid) is a pentacyclic triterpenoid derivative of the beta-amyrin type obtained from the hydrolysis of glycyrrhizic acid, which was obtained from the herb liquorice. It is used in flavoring and it masks the bitter taste of drugs like aloe and quinine. It is effective in the treatment of peptic ulcer and also has expectorant (antitussive) properties. It has some additional pharmacological properties including antiviral, antifungal, antiprotozoal, and antibacterial activities.
Selected research
Market Structure
Global Glycyrrhetinic Acid (CAS 471-53-4) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Glycyrrhetinic Acid (CAS 471-53-4) (also known as Enoxolone or glycyrrhetic acid) is a pentacyclic triterpenoid derivative of the beta-amyrin type obtained from the hydrolysis of glycyrrhizic acid, which was obtained from the herb liquorice. It is used in flavoring and it masks the bitter taste of drugs like aloe and quinine. It is effective in the treatment of peptic ulcer and also has expectorant (antitussive) properties. It has some additional pharmacological properties including antiviral, antifungal, antiprotozoal, and antibacterial activities.
Fujie Pharmaceutical, QHL Pharma, Select Botanical and Tianshan Pharmaceuticals are the leading players in licorice acid (CAS 471-53-4) market, the top 3 accounting for about 48% of the market share.
Asia-Pacific is the largest production region with a market share of about 50%, followed by Europe with about 40%.
Read the full market overview
The report provides an overview of the global Glycyrrhetinic Acid (CAS 471-53-4) market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Glycyrrhetinic Acid (CAS 471-53-4) and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Glycyrrhetinic Acid (CAS 471-53-4) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glycyrrhetinic Acid (CAS 471-53-4) market size, projected growth trends, production technologies, key applications, and end-use industries.
Glycyrrhetinic Acid (CAS 471-53-4) Segment by Company
Fujie Pharmaceutical
Qinghai Lake Pharmaceutical
Select Botanical
Givaudan (Indena S.p.A.)
Alchem International
TIANSHAN Pharmaceuticals
GfN & Selco
Jiangshu Tiansheng Pharmaceutical
Gansu Fanzhi Pharmaceutical
Glycyrrhetinic Acid (CAS 471-53-4) Segment by Content
Above 98%
Below 98%
Glycyrrhetinic Acid (CAS 471-53-4) Segment by Application
Pharmaceutical
Cosmetic
Others
Glycyrrhetinic Acid (CAS 471-53-4) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycyrrhetinic Acid (CAS 471-53-4) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glycyrrhetinic Acid (CAS 471-53-4) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycyrrhetinic Acid (CAS 471-53-4).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Glycyrrhetinic Acid (CAS 471-53-4) market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glycyrrhetinic Acid (CAS 471-53-4) industry.
Chapter 3: Detailed analysis of Glycyrrhetinic Acid (CAS 471-53-4) market competition landscape. Including Glycyrrhetinic Acid (CAS 471-53-4) manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Glycyrrhetinic Acid (CAS 471-53-4) by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Glycyrrhetinic Acid (CAS 471-53-4) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Above 98%
- Below 98%
Applications
- Pharmaceutical
- Cosmetic
- Others
Companies covered
- Fujie Pharmaceutical
- Qinghai Lake Pharmaceutical
- Select Botanical
- Givaudan (Indena S.p.A.)
- Alchem International
- TIANSHAN Pharmaceuticals
- GfN & Selco
- Jiangshu Tiansheng Pharmaceutical
- Gansu Fanzhi Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Glycyrrhetinic Acid (CAS 471-53-4) Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Glycyrrhetinic Acid (CAS 471-53-4) Market Dynamics
- 2.1 Glycyrrhetinic Acid (CAS 471-53-4) Industry Trends
- 2.2 Glycyrrhetinic Acid (CAS 471-53-4) Industry Drivers
- 2.3 Glycyrrhetinic Acid (CAS 471-53-4) Industry Opportunities and Challenges
- 2.4 Glycyrrhetinic Acid (CAS 471-53-4) Industry Restraints
3 Glycyrrhetinic Acid (CAS 471-53-4) Market by Manufacturers
- 3.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Value by Manufacturers (2021-2026)
- 3.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Production by Manufacturers (2021-2026)
- 3.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Average Price by Manufacturers (2021-2026)
- 3.4 Global Glycyrrhetinic Acid (CAS 471-53-4) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Glycyrrhetinic Acid (CAS 471-53-4) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Glycyrrhetinic Acid (CAS 471-53-4) Manufacturers, Product Type & Application
- 3.7 Global Glycyrrhetinic Acid (CAS 471-53-4) Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Glycyrrhetinic Acid (CAS 471-53-4) Players Market Share by Production Value in 2025
- 3.8.3 2025 Glycyrrhetinic Acid (CAS 471-53-4) Tier 1, Tier 2, and Tier 3
4 Glycyrrhetinic Acid (CAS 471-53-4) Market by Type
- 4.1 Glycyrrhetinic Acid (CAS 471-53-4) Type Introduction
- 4.1.1 Above 98%
- 4.1.2 Below 98%
- 4.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Production by Type
- 4.2.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Production by Type (2021-2032)
- 4.2.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Market Share by Type (2021-2032)
- 4.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Value by Type
- 4.3.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Value by Type (2021-2032)
- 4.3.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Value Market Share by Type (2021-2032)
5 Glycyrrhetinic Acid (CAS 471-53-4) Market by Application
- 5.1 Glycyrrhetinic Acid (CAS 471-53-4) Application Introduction
- 5.1.1 Pharmaceutical
- 5.1.2 Cosmetic
- 5.1.3 Others
- 5.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Production by Application
- 5.2.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Production by Application (2021-2032)
- 5.2.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Market Share by Application (2021-2032)
- 5.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Value by Application
- 5.3.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Value by Application (2021-2032)
- 5.3.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Fujie Pharmaceutical
- 6.1.1 Fujie Pharmaceutical Company Information
- 6.1.2 Fujie Pharmaceutical Business Overview
- 6.1.3 Fujie Pharmaceutical Glycyrrhetinic Acid (CAS 471-53-4) Production, Value and Gross Margin (2021-2026)
- 6.1.4 Fujie Pharmaceutical Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 6.1.5 Fujie Pharmaceutical Recent Developments
- 6.2 Qinghai Lake Pharmaceutical
- 6.2.1 Qinghai Lake Pharmaceutical Company Information
- 6.2.2 Qinghai Lake Pharmaceutical Business Overview
- 6.2.3 Qinghai Lake Pharmaceutical Glycyrrhetinic Acid (CAS 471-53-4) Production, Value and Gross Margin (2021-2026)
- 6.2.4 Qinghai Lake Pharmaceutical Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 6.2.5 Qinghai Lake Pharmaceutical Recent Developments
- 6.3 Select Botanical
- 6.3.1 Select Botanical Company Information
- 6.3.2 Select Botanical Business Overview
- 6.3.3 Select Botanical Glycyrrhetinic Acid (CAS 471-53-4) Production, Value and Gross Margin (2021-2026)
- 6.3.4 Select Botanical Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 6.3.5 Select Botanical Recent Developments
- 6.4 Givaudan (Indena S.p.A.)
- 6.4.1 Givaudan (Indena S.p.A.) Company Information
- 6.4.2 Givaudan (Indena S.p.A.) Business Overview
- 6.4.3 Givaudan (Indena S.p.A.) Glycyrrhetinic Acid (CAS 471-53-4) Production, Value and Gross Margin (2021-2026)
- 6.4.4 Givaudan (Indena S.p.A.) Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 6.4.5 Givaudan (Indena S.p.A.) Recent Developments
- 6.5 Alchem International
- 6.5.1 Alchem International Company Information
- 6.5.2 Alchem International Business Overview
- 6.5.3 Alchem International Glycyrrhetinic Acid (CAS 471-53-4) Production, Value and Gross Margin (2021-2026)
- 6.5.4 Alchem International Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 6.5.5 Alchem International Recent Developments
- 6.6 TIANSHAN Pharmaceuticals
- 6.6.1 TIANSHAN Pharmaceuticals Company Information
- 6.6.2 TIANSHAN Pharmaceuticals Business Overview
- 6.6.3 TIANSHAN Pharmaceuticals Glycyrrhetinic Acid (CAS 471-53-4) Production, Value and Gross Margin (2021-2026)
- 6.6.4 TIANSHAN Pharmaceuticals Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 6.6.5 TIANSHAN Pharmaceuticals Recent Developments
- 6.7 GfN & Selco
- 6.7.1 GfN & Selco Company Information
- 6.7.2 GfN & Selco Business Overview
- 6.7.3 GfN & Selco Glycyrrhetinic Acid (CAS 471-53-4) Production, Value and Gross Margin (2021-2026)
- 6.7.4 GfN & Selco Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 6.7.5 GfN & Selco Recent Developments
- 6.8 Jiangshu Tiansheng Pharmaceutical
- 6.8.1 Jiangshu Tiansheng Pharmaceutical Company Information
- 6.8.2 Jiangshu Tiansheng Pharmaceutical Business Overview
- 6.8.3 Jiangshu Tiansheng Pharmaceutical Glycyrrhetinic Acid (CAS 471-53-4) Production, Value and Gross Margin (2021-2026)
- 6.8.4 Jiangshu Tiansheng Pharmaceutical Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 6.8.5 Jiangshu Tiansheng Pharmaceutical Recent Developments
- 6.9 Gansu Fanzhi Pharmaceutical
- 6.9.1 Gansu Fanzhi Pharmaceutical Company Information
- 6.9.2 Gansu Fanzhi Pharmaceutical Business Overview
- 6.9.3 Gansu Fanzhi Pharmaceutical Glycyrrhetinic Acid (CAS 471-53-4) Production, Value and Gross Margin (2021-2026)
- 6.9.4 Gansu Fanzhi Pharmaceutical Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 6.9.5 Gansu Fanzhi Pharmaceutical Recent Developments
7 Global Glycyrrhetinic Acid (CAS 471-53-4) Production by Region
- 7.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Production by Region (2021-2032)
- 7.2.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Production by Region (2021-2026)
- 7.2.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Forecast by Region (2027-2032)
- 7.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Value by Region (2021-2032)
- 7.4.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Value by Region (2021-2026)
- 7.4.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Production Value by Region (2027-2032)
- 7.5 Global Glycyrrhetinic Acid (CAS 471-53-4) Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Glycyrrhetinic Acid (CAS 471-53-4) Production Value (2021-2032)
- 7.6.2 Europe Glycyrrhetinic Acid (CAS 471-53-4) Production Value (2021-2032)
- 7.6.3 Asia-Pacific Glycyrrhetinic Acid (CAS 471-53-4) Production Value (2021-2032)
- 7.6.4 South America Glycyrrhetinic Acid (CAS 471-53-4) Production Value (2021-2032)
- 7.6.5 Middle East & Africa Glycyrrhetinic Acid (CAS 471-53-4) Production Value (2021-2032)
8 Global Glycyrrhetinic Acid (CAS 471-53-4) Consumption by Region
- 8.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Consumption by Region (2021-2032)
- 8.2.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Consumption by Region (2021-2026)
- 8.2.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Glycyrrhetinic Acid (CAS 471-53-4) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Glycyrrhetinic Acid (CAS 471-53-4) Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Glycyrrhetinic Acid (CAS 471-53-4) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Glycyrrhetinic Acid (CAS 471-53-4) Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Glycyrrhetinic Acid (CAS 471-53-4) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Glycyrrhetinic Acid (CAS 471-53-4) Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Glycyrrhetinic Acid (CAS 471-53-4) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Glycyrrhetinic Acid (CAS 471-53-4) Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Glycyrrhetinic Acid (CAS 471-53-4) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Glycyrrhetinic Acid (CAS 471-53-4) Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Glycyrrhetinic Acid (CAS 471-53-4) Value Chain Analysis
- 9.1.1 Glycyrrhetinic Acid (CAS 471-53-4) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Glycyrrhetinic Acid (CAS 471-53-4) Production Mode & Process
- 9.2 Glycyrrhetinic Acid (CAS 471-53-4) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Glycyrrhetinic Acid (CAS 471-53-4) Distributors
- 9.2.3 Glycyrrhetinic Acid (CAS 471-53-4) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst